Fortis Healthcare has reported results for fourth quarter (Q4) and year ended March 31, 2025.
The company has reported a net loss at Rs 42.23 crore for the quarter under review as compared to net profit at Rs 68.33 crore for the same quarter in the previous year. However, total income of the company increased by 21.61% at Rs 413.46 crore for Q4FY25 as compared to Rs 339.98 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 7.44% decline in its net profit at Rs 188.02 crore for fourth quarter ended March 31, 2025 as compared to Rs 203.14 crore for the same quarter in the previous year. However, total income of the company increased by 12.88% at Rs 2,027 crore for Q4FY25 as compared to Rs 1,795.68 crore for the corresponding quarter previous year.
For the year ended March 31, 2025, the company has reported 68.02% decline in its net profit at Rs 63.79 crore as compared to Rs 199.45 crore for the previous year. However, total income of the company increased by 24.16% at Rs 1,644.44 crore for year under review as compared to Rs 1,324.42 crore for year ended March 31, 2024.
For the year ended March 31, 2025, on the consolidated basis, the company has reported 25.44% rise in its net profit at Rs 809.38 crore as compared to Rs 645.22 crore for the previous year. The total income of the company increased by 13.25% at Rs 7,849.69 crore for year under review as compared to Rs 6,931.17 crore for year ended March 31, 2024.
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 7653.85 |
| Max Healthcare Inst | 1010.35 |
| Narayana Hrudayalay | 1803.10 |
| Aster DM Healthcare | 678.60 |
| Global Health | 1078.95 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: